In the current study, a systematic characterisation of SERBP1 expression in human breast cancer is presented for the first time at both the mRNA and the protein level, including a large cohort of breast carcinoma specimens that has been investigated by correlative analysis using clinicopathological parameters and patients’ survival data. This evidence concerns the gene SERBP1 and breast carcinoma.